Literature DB >> 9877196

Laboratory and clinical comparison of preservation media and transport conditions for survival of Actinobacillus actinomycetemcomitans.

R Piccolomini1, G Catamo, G Di Bonaventura, C Picciani, M Paolantonio.   

Abstract

The capacity of clinical isolates and type strains of Actinobacillus actinomycetemcomitans to survive in a new transport medium (AaTM), phosphate-buffered saline (PBS) and Ringer's solution (RS) was evaluated. The effects of exposure to air, transportation time and temperature on viability were also studied. In addition, the culture of A. actinomycetemcomitans from subgingival plaque of patients with different forms of periodontitis was quantified. The results following storage in AaTM, PBS and RS showed that A. actinomycetemcomitans survived better in AaTM than in PBS or RS when transportation times exceeded 20-22 h, and that survival was enhanced by storage at below 12 degrees C. Serotype b strains of A. actinomycetemcomitans were able to survive better than either serotype a or c. In the clinical study the optimal transportation conditions for subgingival plaque containing A. actinomycetemcomitans were AaTM at a temperature of 8 degrees C for 24 h under anaerobic conditions. These conditions resulted in a high survival and isolation rate for A. actinomycetemcomitans without inhibition of the other periodontopathic bacteria isolated from deep periodontal pockets. These findings have practical implications for future multicentre clinical trials in which the transportation of oral specimens over relatively long distances and at different ambient temperatures during various periods of the year are required.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877196     DOI: 10.1099/00222615-47-8-743

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

2.  Aggregatibacter actinomycetemcomitans: From Basic to Advanced Research.

Authors:  Abdelhadi Hbibi; Amal Bouziane; Badiaa Lyoussi; Mimoun Zouhdi; Driss Benazza
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.